HAR1A was shown to have a tumour suppressor role in oral cancer via interaction with Alpha Kinase-1 (ALPK1), and in non-small cell lung cancer via modulation of the Signal Transducers and Activator of Transcription 3 (STAT3) pathways [8, 9]. This evidence concerns the gene ALPK1 and lip and oral cavity carcinoma.